In that sense, VALO reflects a broader shift from building central platforms to enabling connected data ecosystems, supporting both national priorities and cross-border collaboration. The less visible challenge: data variability
Blog
Federated Data Platforms: Unlocking Insights While Respecting Data Reality
Jun 30, 2026
Federated Data Platforms are gaining momentum across healthcare systems, life sciences, and regulatory environments,driven in large part by privacy and General Data Protection Regulation (GDPR) requirements that make exporting patient‑level data increasingly complex. Their promise is compelling: enabling meaningful insights across organisations and countries while keeping sensitive data local and under appropriate governance controls.
Federated platforms as a source of unique insight
At their best, federated data platforms enable insights that would not be achievable through isolated or purely centralised approaches.
By enabling analysis across distributed data sources (while preserving local control, governance, and compliance with applicable legal and regulatory frameworks), federated platforms make it possible to generate system‑wide insight without the risks and constraints of large central data repositories.
In practice, this enables cross‑institution and cross‑country insight, including the ability to:
- Analyse patterns across multiple hospitals or countries
- Compare cohorts that are defined differently in local source systems
- Detect rare events or long‑tail signals that single datasets are too small to expose
These capabilities are particularly important in domains such as oncology and rare diseases, where meaningful patterns often only emerge at scale, and where variation in healthcare delivery and data capture is unavoidable.
While the strengths of federated platforms are often well articulated, the associated challenges are less visible; but no less critical.
One of the most fundamental challenge is data variability.
Different healthcare systems generate different types of data. Even within the same country, system architectures, clinical workflows, coding practices, and levels of digital maturity can vary significantly. In healthcare, inconsistency is not an exception; it is the norm.
New systems are continually introduced, legacy systems persist, and clinical practice evolves faster than data standards. Understanding when, how, and why these changes occur is essential for interpreting federated analytics correctly.
Although automated tools exist to support data validation, robust QA/QC processes must sit at the core of any federated data ecosystem. Without them, the risk is not simply poor data quality, but misleading insights.
Harmonisation: more than adopting a common standard
Federation can simplify governance by avoiding widespread data transfer. However, this benefit comes at the cost of significant data harmonisation effort.
Crucially, harmonisation goes far beyond adopting a common data model such as OMOP, or shared terminologies such as SNOMED. Standards create a foundation; but they do not, by themselves, guarantee comparability.
Without sufficient harmonisation, federated platforms risk producing outputs that look consistent on the surface, but in reality are “comparing apples with oranges.”
In DigiONE I3, this harmonisation effort was substantial and continuous. It required a team capable of operating across traditionally separate domains; effectively acting as a bridge between:
- Clinical considerations, where deep medical expertise is required to validate clinical definitions, diagnostic criteria, and the interpretation of medical data
- Technical considerations, including Extract, Transform, Load (ETL) design, system compatibility, and continuous assessment of data quality and feasibility
- Scope and management considerations, where changes in data definitions or pipelines can impact other systems, teams, and delivery plans, and where project management must account for effort, resources, and long term maintenance
This type of coordination is often underestimated. Yet it is precisely what determines whether a federated platform produces reliable, decision grade insight; or merely well packaged noise.
Security is technical and psychological
Security is another frequently cited strength of federated models, and rightly so. Keeping data local significantly reduces many technical and regulatory risks associated with large central data repositories.
However, security is not only a technical issue. Perceived security matters just as much as actual security.
Trust (among clinicians, institutions, regulators, and the public) is the binding constraint for scale in federated data ecosystems. Even technically robust platforms can struggle with adoption if stakeholders do not feel confident about how data is protected, accessed, and used.
Clear communication, transparent governance, and demonstrable control for data custodians are therefore as important as encryption, access controls, and infrastructure hardening.
Federation succeeds when data is taken seriously
Federated data platforms are not a shortcut around complexity. They are a way of managing it; pragmatically and responsibly.
They succeed when:
- Data variability is acknowledged rather than hidden
- Harmonisation is resourced as an ongoing effort, not a one off exercise
- Clinical, technical, and delivery perspectives are aligned
- Governance and security are designed to build genuine trust
When these elements are in place, federation becomes a powerful enabler: unlocking insights at scale, while respecting the realities of healthcare data and the responsibilities that come with it.
At IQVIA, our experience across federated real world evidence networks, oncology programmes, and national health data initiatives has shown that federation is as much about people, process, and data stewardship as it is about technology.
Handled well, federated platforms do more than connect systems; they connect insight to impact.